| ²é¿´: 946 | »Ø¸´: 1 | ||||||||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßhuye4728½«ÔùËÍÄú 100 ¸ö½ð±Ò | ||||||||
[ÇóÖú]
ÇóÖú»ù½ðÏîÄ¿ÔÎÄ£º»ùÓÚHPLC¼¼ÊõµÄ´úл×éѧ·½·¨É¸Ñ¡ÖÐÒ©ÇàÁúÒ¿¹°©»îÐÔÎïÖÊ
|
||||||||
|
» ²ÂÄãϲ»¶
292Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
»¯Ñ§¹¤³Ì085602 305·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
303Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
334·Ö Ò»Ö¾Ô¸ÎäÀí-080500 ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
299Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
299Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
316Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
czyzsu
ר¼Ò¹ËÎÊ (ÎÄ̳¾«Ó¢)
-

ר¼Ò¾Ñé: +3728 - »ù½ðHEPI: 50
- Ó¦Öú: 3323 (¸±½ÌÊÚ)
- ¹ó±ö: 1
- ½ð±Ò: 308948
- É¢½ð: 2465
- ºì»¨: 686
- Ìû×Ó: 28708
- ÔÚÏß: 7440.5Сʱ
- ³æºÅ: 150213
- ×¢²á: 2005-12-29
- רҵ: »¯Ñ§ÉúÎïѧÓëÉúÎïÓлú»¯Ñ§
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ÉêÇëÊéÕªÒª ÒÔÇàÁúÒ»îÐÔ²¿Î»(AE)ΪÑо¿¶ÔÏó£¬ÒÔHPLC-DAD-MSΪ¼¼Êõƽ̨£¬²ÉÓôúл×éѧ£¨metabonomics£©µÄÑо¿·½·¨£¬Í¨¹ý¶ÔÉúÎïÑùÆ·£¨ÈçÄòÒº¡¢ÑªÇåºÍ×éÖ¯£©´úлÎïµÄ·ÖÎö£¬¶ÔÓ¦ÓÚÌåÄÚ¿¹Ö×Áö¶¯ÎïÄ£Ð͵ÄÒ©Àíѧ¼ì²âÖ¸±ê£¬´Ó´úлÎïÖÐɸѡÓ뿹°©»îÐÔÓÐÏà¹ØÐԵĴúлÎï°Ð±ê£¨metabolite target£©ºÍ´úлÂÖÀª(metabolic profilng)¡£ÒÔ´úлÎï°Ð±ê·ÖÎö ºÍ´úлÂÖÀª·ÖÎöΪָµ¼£¬¿ªÕ¹ÖÐÒ©ÇàÁúÒ¿¹°©»îÐÔÎïÖʵÄ×·×Ù¡¢É¸Ñ¡£¬Ñо¿ÇàÁúÒÂÖоßÓп¹°©»îÐÔµÄÓÐЧ³É·Ö£¨Èº£©¼°×÷ÓûúÀí,½â¾öĿǰÖÐÒ©ÇàÁúÒ¼°ÆäÖÆ¼ÁÖп¹°©×÷ÓõÄÎïÖÊ»ù´¡²»Ã÷È·£¬×÷ÓûúÀí²»Çå³þµÄÎÊÌâ,Ϊ½øÒ»²½¿ª·¢ÒÔÇàÁúÒÂΪÔÁϵĿ¹°©ÐÂÒ©µì¶¨ÀíÂÛ»ù´¡¡£ ±¾ÏîÄ¿ÀûÓôúл×éѧµÄÑо¿Ë¼Â·ºÍÑо¿·½·¨£¬½¨Á¢ÁË´ÓÖÐÒ©¸´ÔÓµÄ"ºÚÉ«"»ò"»ÒÉ«"¶à×é·ÖÌåϵÖÐɸѡ¿¹°©»îÐÔÎïÖÊÐÂģʽ¡£ ÉêÇëÊéÖ÷Ìâ´Ê ÇàÁúÒ»îÐÔ²¿Î»(AE)£»HPLC-DAD-MS£»´úл×éѧ£»¿¹°©»îÐÔ ½áÌâÖÐÎÄÕªÒª Ëæ×ÅÖ×Áö¶ÔÈËÌ彡¿µµÄΣº¦ÈÕÒæÑÏÖØ£¬¿¹Ö×ÁöÑо¿ÒѳÉΪÉúÃü¿ÆÑ§¡¢»¯Ñ§µÈÁìÓòÑо¿µÄÈȵ㡣¿ª·¢ÁÆÐ§¸ß¡¢Ñ¡ÔñÐÔÇ¿¡¢¶¾¸±×÷Óõ͵Äп¹Ö×ÁöÒ©ÎÒѳÉΪ¿¹Ö×ÁöÑо¿ÆÈÇÐÐèÒª½â¾öµÄÄÑÌâ¡£±¾ÏîÄ¿ÒÔÇàÁúÒ»îÐÔ²¿Î»ÎªÑо¿¶ÔÏó£¬ÒÔHPLC-DAD-MSΪ¼¼Êõƽ̨, ´úл×éѧΪÑо¿·½·¨£¬½¨Á¢ÁËɸѡÖÐÒ©¿¹Ö×Áö»îÐԳɷֵÄÐÂģʽ¡£Í¨¹ý¶ÔÇàÁúÒÂÌìȻҩÎﻯѧÑо¿ºÍÉúÎïÑùÆ·£¨ÈçÄòÒº¡¢ÑªÇåºÍ×éÖ¯£©´úлÎïµÄ·ÖÎö£¬¿ªÕ¹ÖÐÒ©ÇàÁúÒÂÖп¹Ö×Áö»îÐÔÎïÖʵÄ×·×ÙºÍɸѡ£¬Ñо¿ÇàÁúÒÂÖоßÓп¹Ö×Áö»îÐÔµÄÓÐЧ³É·Ö£¨Èº£©¼°×÷ÓûúÀí£»½¨Á¢ÁËÇàÁúÒÂÖÐÄ¿±ê»¯ºÏÎïµÄ·ÖÎö·½·¨²¢½øÐÐÁËÓÐЧ³É·ÖÒ©´ú¶¯Á¦Ñ§Ñо¿£»½áºÏ´úл×éѧÔÚÖÐÒ©¶¾ÐÔÑо¿ÖоßÓеÄÓÅÊÆ£¬ÒÔ̽ÌÖÖÐÒ©ÇàÁúÒ¶Խ¡¿µÐ¡Êó´úлӰÏìΪĿ±ê£¬¶Ô¸øÒ©Ð¡ÊóѪ½¬½øÐдúлͼÆ×µÄ·ÖÎö£¬Í¬Ê±¿¼²ìÁËÇàÁúÒÂÌáÈ¡Îï¶ÔСÊó¸ÎÔàºÍÉöÔàÐÎ̬ѧµÄÓ°Ïì¡£½â¾öÁËĿǰÖÐÒ©ÇàÁúÒ¼°ÆäÖÆ¼ÁÖп¹°©×÷ÓõÄÎïÖÊ»ù´¡²»Ã÷È·£¬×÷ÓûúÀí²»Çå³þµÄÎÊÌ⣬Ϊ½øÒ»²½¿ª·¢ÒÔÇàÁúÒÂΪÔÁϵĿ¹Ö×ÁöÐÂÒ©µì¶¨ÀíÂÛ»ù´¡¡£ ½áÌâÓ¢ÎÄÕªÒª Human health is being seriously threatened by cancer and the studies on the anticancer have become the focus in life sciences and chemistry areas. There is an urgent need to develop a kind of high efficacy, high selectivity and low toxicity anticancer drugs. In this project, a new model of the screening anticancer compounds from the husks of walnut (Juglans regia L.) (QLY) was set up based on the metabonomics and HPLC-DAD-MS methods. By the studies of natural products and the metabolic analysis of the biological samples, such as urine, plasma and tissues, the anticancer compounds were tracked and screened. And then, the analysis method of the target compounds in QLY was set up and the pharmacokinetics of active ingredients was also development. Due to the superiority of metabonomics in toxicology research of traditional Chinese medicine, the toxicology of QLY extracts were studied using HPLC based metabonomics. The disturbances of mice plasma induce by QLY extracts were profiled by metabolic fingerprint analysis and the histopathology of liver exposed to QLY extracts showed significant damage. In addition, the structures of these anticancer compounds and the mechanism of anticancer in traditional Chinese medicine QLY and preparations were elucidated. The results indicate that the unclear problems of material basis and mechanism were solved, which is the theoretical basis in the further development of anticancer drugs from the QLY. |
2Â¥2017-01-11 20:22:55













»Ø¸´´ËÂ¥